Get started
Author

Shruti Mitkus

The state-of-the-art of N-of-1 therapies and the IRDiRC N-of-1 development roadmap
2024 · Anneliene H. Jonker, Elena-Alexandra Tataru, et al. · Nature Reviews Drug Discovery · 45
From roadmap to a sustainable end-to-end individualized therapy pathway
2025 · Anneliene H. Jonker, Elena-Alexandra Tataru, et al. · Therapeutic Advances in Rare Disease · 9
A plain language review of the TETON-1 and TETON-2 studies: inhaled treprostinil (Tyvaso) in idiopathic pulmonary fibrosis
2026 · Stephanie Hwang, Maryluz Fuentes, et al. · Figshare
A plain language review of the TETON-1 and TETON-2 studies: inhaled treprostinil (Tyvaso) in idiopathic pulmonary fibrosis
2026 · Stephanie Hwang, Maryluz Fuentes, et al. · Expert Review of Respiratory Medicine
Works count: 4
Citation count: 54
H-index: 2
I10-index: 1
Year
Topic
Type